Ondine Biomedical Inc
Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its primary product is Steriwave, which enables rapid elimination of pathogens associated with healthcare-associated infections. In addition, the company offers a pipeline of products for various indications, including burns, ventilator tube, … Read more
Ondine Biomedical Inc (OBI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -0.665x
Based on the latest financial reports, Ondine Biomedical Inc (OBI) has a cash flow conversion efficiency ratio of -0.665x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-4.57 Million) by net assets (GBX6.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ondine Biomedical Inc - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Ondine Biomedical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ondine Biomedical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ondine Biomedical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alexandria Containers and goods
EGX:ALCN
|
N/A |
|
CHINA SOUTHN AIR-H-
BE:ZNHH
|
N/A |
|
HBSA3F
SA:HBSA3F
|
N/A |
|
China Networks International Holdings Ltd
PINK:CNWHF
|
-0.750x |
|
SHS
VN:SHS
|
N/A |
|
ASHANTE GOLD CORPORATION
GSE:ASG
|
N/A |
|
SIETEL 5% CUM PF
AU:SSLPA
|
N/A |
|
SDM SE INH O.N.
F:75S
|
N/A |
Annual Cash Flow Conversion Efficiency for Ondine Biomedical Inc (2001–2024)
The table below shows the annual cash flow conversion efficiency of Ondine Biomedical Inc from 2001 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX6.88 Million | GBX-15.49 Million | -2.252x | +65.60% |
| 2023-12-31 | GBX2.08 Million | GBX-13.65 Million | -6.548x | -366.49% |
| 2022-12-31 | GBX11.64 Million | GBX-16.34 Million | -1.404x | -231.98% |
| 2021-12-31 | GBX29.66 Million | GBX-12.54 Million | -0.423x | -325.93% |
| 2020-12-31 | GBX-33.83 Million | GBX-6.33 Million | 0.187x | -35.38% |
| 2019-12-31 | GBX-26.07 Million | GBX-7.55 Million | 0.290x | -48.60% |
| 2018-12-31 | GBX-17.90 Million | GBX-10.08 Million | 0.563x | -29.97% |
| 2017-12-31 | GBX-6.55 Million | GBX-5.27 Million | 0.805x | +108.26% |
| 2010-12-31 | GBX279.19K | GBX-2.72 Million | -9.743x | -262.05% |
| 2009-12-31 | GBX1.28 Million | GBX-3.44 Million | -2.691x | +59.70% |
| 2008-12-31 | GBX1.34 Million | GBX-8.93 Million | -6.677x | -508.20% |
| 2007-12-31 | GBX10.84 Million | GBX-11.90 Million | -1.098x | -67.96% |
| 2006-12-31 | GBX16.59 Million | GBX-10.84 Million | -0.654x | -28.61% |
| 2005-12-31 | GBX16.50 Million | GBX-8.39 Million | -0.508x | -274.72% |
| 2003-08-31 | GBX-227.62K | GBX-66.20K | 0.291x | +264.97% |
| 2002-08-31 | GBX-143.28K | GBX25.26K | -0.176x | -396.57% |
| 2001-08-31 | GBX1.39 Million | GBX-49.50K | -0.036x | -- |